Search clinical trials for: Sevelamer
Total 96 results
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedKidney Diseases | End-Stage Renal Disease | Chronic Renal InsufficiencyUnited States
-
University Hospital Birmingham NHS Foundation TrustGenzyme, a Sanofi CompanyCompletedCardiovascular Diseases | Kidney Failure, ChronicUnited Kingdom
-
Genzyme, a Sanofi CompanyTerminatedChronic Kidney Disease | HyperphosphatemiaGermany, Greece, Portugal, Austria, France, Hungary, Italy, Spain, Sweden
-
Genzyme, a Sanofi CompanyCompletedRenal Failure ChronicRussian Federation
-
Brigham and Women's HospitalTerminatedInflammation | Cardiovascular Disease | Atherosclerosis | Hyperphosphatemia | DialysisUnited States
-
Fan Fan HouUnknown
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited States
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Kissei Pharmaceutical Co., Ltd.CompletedHemodialysis | HyperphosphatemiaJapan
-
Milton S. Hershey Medical CenterGenzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited States
-
ArdelyxCompletedEnd Stage Renal Disease | HyperphosphatemiaUnited States
-
Astellas Pharma IncCompletedA Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisChronic Kidney Disease | HyperphosphatemiaJapan
-
University of California, Los AngelesLoma Linda UniversityCompletedSecondary HyperparathyroidismUnited States
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney Disease | HyperphosphataemiaFrance, Germany, Spain, Netherlands, Italy, Austria, Denmark
-
Genzyme, a Sanofi CompanyCompletedDose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on HemodialysisChronic Kidney Disease | Chronic Kidney Disease on HemodialysisChina
-
Chugai PharmaceuticalCompletedHyperphosphatemiaUnited States
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney Disease | HyperphosphatemiaUnited States, France, Germany, Lithuania, Poland
-
Alebund PharmaceuticalsCompletedChronic Kidney Diseases | HyperphosphatemiaChina
-
ShireCompletedChronic Kidney Disease, Stage 5United States, Germany, Puerto Rico, United Kingdom
-
Ineos Healthcare LimitedCompletedChronic Kidney FailureUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney Disease | HyperphosphatemiaUnited Kingdom, Australia, Denmark, France, Germany
-
Amgen Research (Munich) GmbHCompleted
-
Shanghai Alebund Pharmaceuticals LimitedCompleted
-
SanofiCompleted
-
ArdelyxCompletedHyperphosphatemiaUnited States
-
Ineos Healthcare LimitedTerminatedChronic Kidney FailureUnited States, Italy, Brazil, Belgium, United Kingdom, Estonia, Bulgaria, Serbia, Israel, Czech Republic, Hungary, Lithuania, Mexico, Slovakia, South Africa
-
Novartis PharmaceuticalsCompletedHyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement TherapyGermany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
-
University of ZurichCompleted
-
ArdelyxAstraZenecaCompletedHealthyUnited States
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | Renal DialysisJapan
-
Zhi-Hong Liu, M.D.Terminated
-
The University of Hong KongCompleted
-
Kenneth R. Phelps, M.D.Genzyme, a Sanofi CompanyCompletedHyperparathyroidism | Chronic Kidney DiseaseUnited States
-
Panion & BF Biotech Inc.Shandong Weigao Panion Pharmaceutical Co. Ltd.CompletedEnd Stage Renal Disease | ESRD | HyperphosphatemiaChina
-
University Hospital, Gentofte, CopenhagenSanofiCompletedDiabetes Mellitus, Type 2Denmark
-
Novartis PharmaceuticalsCompletedChronic Kidney DiseaseTaiwan, Japan
-
Vifor Fresenius Medical Care Renal PharmaCompletedHyperphosphatemia | Chronic Kidney Disease Requiring Chronic DialysisChina
-
Daiichi Sankyo, Inc.CompletedHyperphosphatemiaUnited States
-
Centre Hospitalier Universitaire, AmiensGenzyme, a Sanofi CompanyCompletedChronic Renal FailureFrance
-
Genzyme, a Sanofi CompanyCompletedKidney Failure, ChronicUnited States, Puerto Rico
-
Vifor PharmaFresenius Medical Care North AmericaCompletedChronic Kidney Disease Requiring Chronic DialysisLatvia, United States, South Africa, Belgium, Croatia, Germany, Poland, Romania, Serbia, Ukraine, United Kingdom, Austria, Czech Republic, Lithuania, Russian Federation
-
Mitsubishi Tanabe Pharma CorporationCompletedChronic Kidney Disease | HyperphosphatemiaFrance, Poland, United Kingdom, Spain, South Africa, Australia, Czech Republic, Germany, Hungary, Italy, Austria
-
Mitsubishi Tanabe Pharma CorporationCompletedChronic Kidney Disease | Hyperphosphatemia | DialysisFrance, Poland, Ukraine, United Kingdom, Spain, Serbia, South Africa, Russian Federation, Czech Republic, Germany, Hungary, Italy, Austria, Macedonia, The Former Yugoslav Republic of, Malaysia
-
Medical University of LodzShireCompleted
-
Sinomune Pharmaceutical Co., LtdCompletedEnd Stage Renal Disease | ESRD | HyperphosphatemiaChina
-
University Hospital, Gentofte, CopenhagenSanofiCompleted
-
Genzyme, a Sanofi CompanyManipal Acunova Ltd.Completed
-
Genzyme, a Sanofi CompanyCompleted